Page last updated: 2024-08-24

plerixafor and T-Cell Lymphoma

plerixafor has been researched along with T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bachier, C; Elayan, MM; Horowitz, JG; Magraner, JM; Shaughnessy, PJ	1

Other Studies

1 other study(ies) available for plerixafor and T-Cell Lymphoma

Article	Year
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:11 Topics: Adult; Aged; Antigens, CD34; Benzylamines; Blood Platelets; Cost-Benefit Analysis; Cyclams; Female; Filgrastim; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Length of Stay; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Multiple Myeloma; Neoplasms, Plasma Cell; Neutrophils; Retrospective Studies; Transplantation, Autologous	2015

Article

Year

Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:11

Topics: Adult; Aged; Antigens, CD34; Benzylamines; Blood Platelets; Cost-Benefit Analysis; Cyclams; Female; Filgrastim; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Length of Stay; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Multiple Myeloma; Neoplasms, Plasma Cell; Neutrophils; Retrospective Studies; Transplantation, Autologous

2015